Investigators recently launched the CHASING COVID Cohort study to help physicians and policymakers understand the impact of our public health response to the pandemic on clinical outcomes, and to prepare for future health crises.
Specifically, the CHASING COVID study will gather definitive evidence about whether antibodies are protective against reinfection.
“There is a critical need to investigate and characterize the evolving epidemiology of any deadly pandemic caused by a novel pathogen,” Denis Nash, PhD, MPH, told Healio Primary Care.
Nash, the executive director of the City
Uncategorized